MedTrace Logo

Effect of Continuous Glucose Monitoring System Alerts on Diabetes Management in the Hospital

NCT05941286 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 533

Last updated 2025-12-23

No results posted yet for this study

Summary

Current continuous glucose monitoring (CGM) devices provide features that alert for current and impending adverse glycemic events.This trial aims to examine whether these glucose alerts provided added benefit on glycemic outcomes in patients with type 1 or 2 diabetes who required intensive insulin therapy during hospitalization.

Conditions

Interventions

DEVICE

CGM system with both glucose predictive alerts and threshold alerts on

the cloud-based real-time continuous glucose monitoring and management system with both glucose predictive alerts and threshold alerts on

DEVICE

CGM system with only glucose threshold alerts on

the cloud-based real-time continuous glucose monitoring and management system with only glucose threshold alerts on

DEVICE

CGM system with glucose alerts off

the cloud-based real-time continuous glucose monitoring and management system with glucose predictive/threshold alerts off

Sponsors & Collaborators

  • Shanghai 6th People's Hospital

    lead OTHER

Principal Investigators

  • Jian Zhou · Shanghai 6th People's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-18
Primary Completion
2024-12-16
Completion
2024-12-16
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05941286 on ClinicalTrials.gov